Resalis Therapeutics Appoints Almut Nitsche as Chief Medical and Development Officer
Feb 1, 2024 Resalis Therapeutics Appoints Almut Nitsche as Chief Medical and Development Officer View PDF
Resalis Therapeutics Raises €10 Million Series A to Complete First Clinical Trial for RES-010 in Obesity
Jan 4, 2024 Resalis Therapeutics Raises €10 Million Series A to Complete First Clinical Trial for RES-010 in Obesity View PDF
Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Feb 22, 2023 Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases View PDF
